News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma
Photo of Veronica González-Calle taken from www.sehh.es
Dec 16, 2024, 08:42

PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma

Muzaffar Qazilbash, Stem Cell Transplant Physician and Clinical Researcher at MD Anderson Cancer Center, shared insights on an article by Veronica González-Calle et al. on X:

“High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience. N=1304, Gain 1q seen in 43% patients, all others in <10%. t(4;14), del 17p (>20% cells) and Gain 1q => shorter PFS and OS.”

High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Authors: Veronica González-Calle, Paula Rodriguez-Otero, Maria J. Calasanz, Manuela Guijarro, Joaquin Martínez-López, Laura Rosiñol, Miguel T. Hernández, Ana I. Teruel, Mercedes Gironella, Albert Oriol, Javier de la Rubia, Ana P. González-Rodríguez, Joan Bargay, Felipe de Arriba, Luis Palomera, Marta-Sonia González-Pérez, Anna Sureda, Enrique Ocio, Juan J. Lahuerta, Joan Bladé, Jesus F. San Miguel, Maria V. Mateos, Norma C. Gutiérrez

PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma

cancer cytogenetics del 17p Gain 1q Hematology high-risk cytogenetic abnormalities multiple myeloma Muzaffar Qazilbash myeloma research OncoDaily Oncology overall survival PETHEMA-GEM progression-free survival t(4;14)
Special Coverage
Blog
Dec 16, 2024, 08:42
PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma
Science
Dec 16, 2024, 08:37
Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs
Insight
Dec 16, 2024, 08:33
Jarushka Naidoo: KN867 trial shows no EFS benefit for SBRT+Pembro in NSCLC
Blog
Dec 16, 2024, 08:29
Herbert Loong: Role of pulmonary metastectomies in osteosarcoma patients highlighted
Science
Dec 16, 2024, 08:25
Laura Bukavina: Higher complications in ileal conduit patients versus neobladder patients
Blog
Dec 16, 2024, 08:20
Francisco J. Esteva: Addressing gaps in real-world oncology care through data studies
Insight
Dec 16, 2024, 08:08
Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH
Blog
Dec 16, 2024, 08:02
Roupen Odabashian: Revolutionizing healthcare with AI insights from Dyania Health
Blog
Dec 16, 2024, 07:54
Raya Poghosyan: Looking for remote medical transcriptionist opportunities
Blog
Dec 16, 2024, 07:49
The 2025 National Congress is coming to Rome - AIEOP
Blog
Dec 16, 2024, 07:42
Dr. Daniel Anaya appointed as Chair of GI Surgical Oncology - Moffitt Cancer Center
Blog
Dec 16, 2024, 07:33
Sahar Mansour: First Time at OncoEgypt Conference: A Remarkable Experience